Riverview Trust CO Denali Therapeutics Inc. Transaction History
Riverview Trust CO
- $99.1 Million
- Q1 2025
A detailed history of Riverview Trust CO transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Riverview Trust CO holds 1,171 shares of DNLI stock, worth $18,724. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,171Holding current value
$18,724% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
237Shares Held
111MCall Options Held
80KPut Options Held
36.8K-
Black Rock Inc. New York, NY13.2MShares$211 Million0.01% of portfolio
-
Baillie Gifford & CO12.1MShares$193 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$189 Million0.0% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$87.6 Million0.02% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U05.36MShares$85.6 Million0.55% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.15B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...